Athira Pharma
IPOBothell, United States · $85.0M raised
- Headquarters
- Bothell, Washington
- Employees
- 11–50
- Business Model
- B2B
- Website
- athira.com
- Total Funding
- $85.0M
- Last Round
- $85.0M Series BJun 2020
- Rounds
- 1
About
Clinical-stage biopharmaceutical company developing small molecules to restore neuronal health.
Summary
Athira Pharma is a Biotech company based in Bothell, United States. It has raised $85.0M in total across 1 round, most recently a $85.0M Series B round in Jun 2020. Investors include Perceptive Advisors and RTW Investments.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...